Education
Timely Topics in Transplantation Webinar Series
November 04, 2020
After participating in this webinar, the attendee will be able to:
- Describe the nature of disparities in transplantation in the US
- Identify factors that are driving disparities in transplantation - using kidney transplantation as a case study
- Highlight examples of multi-level strategies to address disparities in transplantation
Speakers:
- Tanjala Purnell, MPH, PhD • Director of Education, Johns Hopkins Center for Health Equity, Baltimore, MD
- Larissa Myaskovsky, PhD • Professor of Internal Medicine & Director, Center for Healthcare Equity in Kidney Disease, University of New Mexico Health Sciences Center, Albuquerque, NM
Moderator:
- Winfred Williams, Jr., MD • Associate Chief, Division of Nephrology, Associate Professor of Medicine, Harvard Medical School, Boston, MA
AST would like to thank the Psychosocial and Ethics Community of Practice (PSECOP), in conjunction with the Pediatric Community of Practice (PCOP) and Women's Health Community of Practice (WHCOP), for recommending "Disparities in Access to Transplantation" as a topic for the 2020-2021 T3 series. Learn more about AST's COPs at www.myast.org/cops.
January 13, 2021
Q&A Handout: Covering speaker responses to questions not addressed during the live session.
After participating in this webinar, the attendee will be able to:
- Describe implementation and optimization of vaccination in the pre- and post-transplant settings.
- Review current recommendations for vaccination of the transplant population.
- Recognize the pipeline of vaccine development that impacts transplant patients including COVID vaccines.
Speakers:
- Michael Green, MD, MPH • Professor of Pediatrics and Surgery, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA
- Deepali Kumar, MD, MSc, FRCPC, FAST • Professor of Medicine, Transplant Centre, University Health Network, Toronto, ON
Moderator:
- Lara Danziger-Isakov, MD, MPH • Professor of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
AST would like to thank the Infectious Disease Community of Practice (IDCOP) and the Pediatric Community of Practice (PCOP) for recommending "Optimizing Vaccination in Transplant Candidates and Recipients" as a topic for the 2020-2021 T3 series. Learn more about AST's COPs at www.myast.org/cops.
May 20, 2020
Speakers:
Kelly Schlendorf, MD, MHS • Assistant Professor of Medicine, Vanderbilt Heart and Vascular Institute, Nashville, TN
Marcelo Cypel MD, MSc, FACS, FRCSC • Associate Professor of Surgery, University of Toronto (UHN), Toronto, ON
Moderator:
Daniel Kaul, MD • Professor of Internal Medicine, University of Michigan, Ann Arbor, MI
After participating in this webinar, the attendee will be able to:
- Understand the evolution of and current state of knowledge using HCV donors (NAT+/-) for heart transplantation
- Understand the evolution of and current state of knowledge using HCV donors (NAT+/-) for lung transplantation
- Describe future directions for utilization of HCV donors (NAT+/-) for thoracic organ transplantation
AST would like to thank the Infectious Disease (IDCOP), Kidney Pancreas (KPCOP), and Liver and Intestinal (LICOP) Communities of Practice for each recommending "HCV" as a topic for the 2019-2020 T3 series. The concept was expanded into two HCV NAT+/- sessions, one covering "HCV NAT+/- in Abdominal Organ Transplantation" and another covering "HCV NAT+/- in Thoracic Organ Transplantation." Learn more about AST's COPs at www.myast.org/cops.
May 27, 2020
Speakers:
Norah Terrault, MD, MPH • Professor of Medicine, University of Southern California, Los Angeles, CA
Deirdre Sawinski, MD • Associate Professor of Medicine, University of Pennsylvania, Philadelphia, PA
Moderator:
Christine Durand, MD • Associate Professor of Medicine, Johns Hopkins University, Baltimore, MD
After participating in this webinar, the attendee will be able to:
- Understand the evolution of and current state of knowledge using HCV donors (NAT+/-) for liver transplantation
- Understand the evolution of and current state of knowledge using HCV donors (NAT+/-) for kidney transplantation
- Describe future directions for utilization of HCV donors (NAT+/-) for abdominal organ transplantation
AST would like to thank the Infectious Disease (IDCOP), Kidney Pancreas (KPCOP), and Liver and Intestinal (LICOP) Communities of Practice for each recommending "HCV" as a topic for the 2019-2020 T3 series. The concept was expanded into two HCV NAT+/- sessions, one covering "HCV NAT+/- in Abdominal Organ Transplantation" and another covering "HCV NAT+/- in Thoracic Organ Transplantation." Learn more about AST's COPs at www.myast.org/cops.
April 15, 2020
Speakers:
Marina Serper, MD, MS • Assistant Professor of Medicine, University of Pennsylvania Hospital, Philadelphia, PA
David Taber, PharmD, MS, BCPS • Professor, Medical University of South Carolina (MUSC), Charleston, SC
Moderator:
Linda Ohler, MSN, RN, CCTC, FAAN • Associate Director, Quality, Regulatory and Education, New York University Langone Medical Center, New York, NY
After participating in this webinar, the attendee will be able to:
- Describe the background and potential applications of telemedicine in transplantation.
- Identify possible barriers to widespread implementation of telemedicine prior to COVID-19.
- Discuss recent changes in regulatory barriers and telemedicine use in the COVID-19 era.
- Describe common mHealth applications used to manage medications and how these can potentially be used by transplant patients to improve adherence and reduce medication errors.
- Explain how dashboards can improve the efficient and effective monitoring of high-risk populations, including transplant recipients.
AST would like to thank the Transplant Administration and Quality Management Community of Practice (TxAQM COP) for recommending "advanced technology in transplant care" as a topic for the 2019-2020 T3 series. Learn more about AST's COPs at www.myast.org/cops.
February 05, 2020
Speakers:
Richard Formica, MD • Professor of Medicine, Yale University, New Haven, CT
William Applegate • AST Director of Government Relations; Senior Policy Advisor, Bryan Cave Leighton Paisner, St. Louis, MO & Washington D.C.
Moderator:
Beau Kelly, MD, MBA, FACS, FAST • Surgical Director, DCI Donor Services, Inc., Sacramento, CA
Objectives for the "Breaking News in Federal Policy in Organ Transplantation" webinar include:
- Summarizing current landscape for proposed legislation that impacts OPO performance, organ allocation, and organ transplantation.
- Reviewing the possible implications of the recent Executive Order on Improving Kidney Care.
- Exploring critical information to developing strategy and a path forward for an AST position statement.
This topic was developed by the AST Education Committee in response to recent policy and legislation activity related to the "Executive Order on Advancing American Kidney Health," the "Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019" (the "Immuno Bill"), and other topics that are important to the field of transplantation.
November 06, 2019
Supplemental material on how to address vaccine hesitancy in the transplant population:
"Reducing the Underimmunization of Transplant Recipients" (Published Online: December 4, 2017. doi:10.1001/jamapediatrics.2017.3990)
Supplemental information on Plan B, as discussed during the question and answer portion of the webinar:
The Plan B pill is safe for transplant recipients to take (Krajewski C, Sucato G. Reproductive health care after transplantation. Best Pract Res Clin Obstet Gynaecol. 2014 Nov;28(8):1222-34.). Visit the CDC website for more information on classifications for emergency contraception and solid organ transplant.
Speakers:
Lisa Coscia, RN, BSN, CCTC • Research Coordinator, Transplant Pregnancy Registry, Philadelphia, PA
Monica Ardura, DO, MSCS • Medical Director of the Host Defense Program, Nationwide Children's Hospital, Columbus, OH
Moderator:
Melissa Meyers, MD, MSCE • Locum Tenens Pediatric Nephrologist, Rainbow Babies and Children's Hospital, Cleveland, OH
Objectives for the "Sexual Health and Monitoring Recommendations for Transplant Recipients" webinar include:
- Reviewing the safety and efficacy of hormonal contraceptive options in pediatric and young adult transplant recipients.
- Summarizing sexually transmitted infection screening, treatment, and management for pediatric and young adult solid organ transplant recipients.
- Discussing strategies to expand sexual health education for pediatric and young adult solid organ transplant recipients.
AST would like to thank the Pediatric Community of Practice (PCOP), in conjunction with the Infectious Disease Community of Practice (IDCOP) and Women's Health Community of Practice (WHCOP), for recommending "sexual health and monitoring recommendations for transplant recipients" as a topic for the 2019-2020 T3 series. Learn more about AST's COPs at www.myast.org/cops.
March 24, 2020
Speakers:
Angela Caliendo, MD, PhD • Professor and Executive Vice Chair of Medicine, Warren Alpert Medical School of Brown University, Providence, RI
Kimberly Hanson, MD, MHS • Associate Professor of Medicine and Pathology, University of Utah School of Medicine, Salt Lake City, UT
Moderator:
Deepali Kumar, MD, FRCPC, MSc • Professor of Medicine, University of Toronto, Toronto, ON
Objectives for the "Diagnostic Stewardship in Solid Organ Transplantation" webinar includes discussion of:
- Pulmonary infections (PCP PCR vs DFA vs both; GM vs asp PCR or fungal panel PCR, metagenomic sequencing, and host response).
- Transplant viruses (CMV, BK, adeno).
- Respiratory and GI panels.
- Detecting pathogens through sequencing of microbial cell-free DNA.
AST would like to thank the Infectious Disease Community of Practice (IDCOP) and the Transplant Diagnostics Community of Practice (TxDx COP) for recommending diagnostic stewardship in infectious diseases as a topic for the 2019-2020 T3 series. Learn more about AST's COPs at www.myast.org/cops. This Timely Topics in Transplantation webinar was generously supported by Viracor.
October 02, 2019
Q&A Handout: Covering speaker responses to questions not addressed during the live session.
Speakers:
Barbara Murphy, MD, MB, BAO, BCh, FRCPI • Murray M. Rosenberg Professor of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY
Peter Nickerson, BSc (Med), MD, FRCPC, FCAHS • Distinguished Professor of Internal Medicine and Immunology, University of Manitoba Max Rady College of Medicine, Winnipeg, MB
Moderator:
Peter Heeger, MD • Professor of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY
Objectives for the "Non-invasive Biomarkers for Allograft Rejection" webinar include:
- Discussing the role of Pre-Transplant HLA Molecular Mismatch as a Prognostic Biomarker of Primary Alloimmunity.
- Discussing the role of Pre-Transplant HLA Molecular Mismatch as a Predictive Biomarker of CNI-based therapy requirements to control Primary Alloimmunity.
- Discussing the impact of subclinical rejection on longterm survival and the need for non-invasive markers of allograft rejection.
- Discussing the role of peripheral gene expression for the detection of subclinical rejection.
AST would like to thank the Community of Transplant Scientists (COTS) and the Transplant Diagnostics Community of Practice (TxDx COP) for recommending biomarkers for allograft rejection as a topic for the 2019-2020 T3 series. Learn more about AST's COPs at www.myast.org/cops.
December 17, 2019
Speakers:
Robert Brown, MD, MPH • Gladys and Roland Harriman Professor of Medicine, Weill Cornell Medical College, New York, NY
Akhil Shenoy, MD, MPH • Assistant Professor of Psychiatry, Columbia University Department of Psychiatry, New York, NY
Moderator:
Michael Curry, MD • Associate Professor of Medicine, Harvard Medical School, Boston, MA
Objectives for the "Transplanting Individuals with Alcohol-related Hepatitis: Multidisciplinary Evaluation and Management" webinar include enabling the attendee to:
- Appreciate the changing landscape of liver transplantation for patients with alcohol use disorder (AUD) and alcohol related liver disease (ALD).
- Describe the diagnosis of AUD and distinguish the various treatments of AUD and how they work.
- Recognize the key management aspects of and role of transplant evaluation in alcohol-related hepatitis from a medical and psychosocial perspective.
AST would like to thank the Psychosocial and Ethics Community of Practice (PSECOP) for recommending "transplanting individuals with alcoholic hepatitis" as a topic for the 2019-2020 T3 series. Learn more about AST's COPs at www.myast.org/cops.